Biogen Message Board - Msg: 3180020

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen

BIIB 167.12

-0.5%

9:49 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DubM who wrote (537)	1/15/1998 6:00:00 PM
From: pragat	Read Replies (1) of 1686

WOW! Ahead of concensus estimates (.39 for the quarter, 1.15 for the year). Technicals, management, and fundamentals look pretty solid. Management continues to execute their business strategy in terms of profitability, marketshare, and new product pipeline. The recent strategic alliance with Merck is another significant milestone. Biogen demonstrates industry leadership, quality, and value as it relates to its stock price. Merrill confirmed the "value" aspect today. Overall, the stock is well-positioned for a ride up (yes, capital appreciation).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next